ARQT Q1 2022 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$229,000

Operating Income

-$63M

Net Income

-$64M

EPS (Diluted)

$-1.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$364M

Total Liabilities

$110M

Stockholders' Equity

$254M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$229,000	-$178,000	-28.7%
Operating Income	-$63M	-$36M	-73.6%
Net Income	-$64M	-$36M	-78.5%